Literature DB >> 2007943

Muscle carnitine deficiency in patients using valproic acid.

Y Shapira1, A Gutman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2007943     DOI： 10.1016/s0022-3476(05)83396-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Sodium valproate-induced myopathy in a child.

Authors:  Riaz Ahmed
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

2.  Valproic Acid and topiramate induced hyperammonemic encephalopathy in a patient with normal serum carnitine.

Authors:  Martha G Blackford; Stephanie T Do; Thomas C Enlow; Michael D Reed
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 3.  Carnitine deficiency-induced cardiomyopathy.

Authors:  D J Paulson
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 4.  Treatment of carnitine deficiency.

Authors:  S C Winter
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 5.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 6.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

7.  Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.

Authors:  Amit Sharma; Siddhartha Sinha; Amit Narang; Dushyant K Chouhan; Sumit Gupta
Journal:  Sultan Qaboos Univ Med J       Date:  2020-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.